The BZW1 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell pool from the HT29 human colorectal adenocarcinoma line, featuring targeted disruption of the BZW1 gene. This polyclonal population introduces loss-of-function mutations across a heterogeneous cell mix, enabling robust functional studies without clonal artifacts. The pooled format captures diverse editing events, providing a physiologically relevant system for investigating gene function.
The parental HT29 cell line is an adherent epithelial model originating from a human colorectal adenocarcinoma, harboring mutations in TP53, APC, and BRAF (V600E). These oncogenic drivers activate MAPK signaling and perturb growth control, mirroring colorectal tumor biology. HT29 cells are widely used to study cancer signaling, therapeutic responses, and drug resistance, particularly under the influence of mutant p53 and BRAF. This genetic context shapes stress responses and apoptosis, making it an ideal platform for interrogating BZW1-dependent pathways.
BZW1 encodes an eIF5-mimic translation factor and guanine nucleotide exchange factor for eIF2. It interacts with eIF2 subunits, eIF5, and the 40S ribosome to regulate ternary complex formation and translation initiation. As a core component of the integrated stress response (ISR), BZW1 is activated by eIF2?? kinases??PERK, GCN2, PKR, and HRI??upon ER stress or amino acid deprivation. Its activity promotes selective ATF4 mRNA translation, inducing downstream effectors such as CHOP and GADD34. This BZW1?CeIF2?CATF4 axis intersects with mTOR signaling, linking nutrient and energy status to translational output. Disruption of BZW1 impairs stress-induced gene expression, compromising adaptive responses.
In the HT29 colorectal adenocarcinoma background, BZW1 knockout provides a powerful model to explore ISR dependence amidst oncogenic signaling. The concurrent mutant p53 and BRAF(V600E) mutations generate proteotoxic strain, intensifying reliance on BZW1-driven translation for survival. This polyclonal knockout is expected to sensitize cells to ER stress and amino acid limitation, potentially reversing adaptive drug resistance. The heterogeneous population mimics intratumoral variation, enhancing translational relevance for studies of colorectal cancer progression and treatment susceptibility.
Research applications encompass translational control, stress biology, and cancer cell adaptation. Endpoint assays include western blotting for ATF4, CHOP, and GADD34; RT-qPCR for stress target gene expression; and polysome profiling to assess ribosome dynamics. Functional readouts such as cell viability and flow cytometry-based apoptosis detection under stress conditions reveal ISR-dependent survival mechanisms. The polyclonal pool is suitable for high-throughput screening of ISR modulators. For further details or ordering, contact Ascent Research.
